Education
About Us
Working with TipRanks
Follow Us
GENW - ETF AI Analysis
Top Page
Genter Capital International Dividend ETF (GENW)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several top holdings, such as Barclays and Banco Bilbao, have shown strong year-to-date performance, supporting the ETF’s overall returns.
Low Expense Ratio
The ETF has a relatively low expense ratio, making it cost-effective compared to many actively managed funds.
Sector Diversification
The ETF spreads its investments across multiple sectors, reducing the risk of being overly reliant on one industry.
Negative Factors
High Geographic Concentration
The ETF has over 96% exposure to U.S. companies, limiting diversification across global markets.
Underperforming Holdings
Some holdings, such as Enbridge and Telefonaktiebolaget LM Ericsson, have lagged in year-to-date performance, which could drag on overall returns.
Heavy Financial Sector Weighting
With over 33% of the portfolio in financials, the ETF is highly exposed to risks specific to this sector.
GENW vs. SPDR S&P 500 ETF (SPY)
AUM2.84M
RegionGlobal
Expense Ratio0.38%
Beta0.53
IssuerGenter Capital
Inception DateJan 06, 2025
Dividend Yield2.65%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,007
30 Day Avg. Volume1,906
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GENW Summary
The Genter Capital International Dividend ETF (GENW) is designed for investors who want to earn steady income through dividends from a mix of international companies. This ETF focuses on high-dividend stocks across various industries, such as financials and healthcare, and includes well-known companies like Mitsubishi UFJ and Barclays. It provides diversification by investing in businesses from different sectors and countries, although most of its holdings are based in the U.S. Someone might consider investing in GENW to grow their portfolio with reliable income from dividends. However, new investors should know that the ETF’s performance can be affected by market fluctuations and changes in global economic conditions.
How much will it cost me?The Genter Capital International Dividend ETF (GENW) has an expense ratio of 0.38%, meaning you’ll pay $3.80 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it is actively managed, focusing on selecting high-dividend international stocks to maximize returns for investors.
What would affect this ETF?GENW's focus on high-dividend international stocks could benefit from stable or growing global economic conditions, especially in sectors like Financials and Industrials, which make up a significant portion of its holdings. However, rising interest rates or economic slowdowns in key regions could negatively impact dividend-paying companies, particularly in sectors like Consumer Defensive and Energy. Regulatory changes or geopolitical tensions in countries where top holdings like Mitsubishi UFJ and Barclays operate could also influence the ETF's performance.
GENW Top 10 Holdings
The Genter Capital International Dividend ETF (GENW) leans heavily on financial stocks, with names like Barclays and Banco Bilbao driving steady gains thanks to strong earnings and solid dividend payouts. AstraZeneca is a standout in the healthcare sector, rising on robust product pipeline developments, while ABB Ltd in industrials has been lagging, weighed down by regional challenges. The fund’s global exposure adds diversification, but its concentration in financials means performance hinges on this sector’s stability. Overall, GENW offers a mix of rising stars and steady dividend payers, though some holdings are losing steam.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Barclays | 5.08% | $144.67K | $78.82B | 70.28% | 77 Outperform | |
| Mitsubishi UFJ | 4.66% | $132.76K | $176.98B | 31.03% | 77 Outperform | |
| Sumitomo Mitsui | 4.65% | $132.39K | $117.93B | 20.50% | 76 Outperform | |
| Banco Bilbao | 4.13% | $117.67K | $125.21B | 130.43% | 73 Outperform | |
| ABB Ltd | 3.77% | $107.39K | $129.52B | 24.11% | 77 Outperform | |
| Enel SpA Unsponsored ADR | 3.65% | $104.06K | $105.05B | 43.72% | 66 Neutral | |
| AstraZeneca | 3.50% | $99.66K | $283.39B | 35.02% | 79 Outperform | |
| Enbridge | 3.47% | $99.00K | $106.61B | 12.75% | 72 Outperform | |
| Telefonaktiebolaget LM Ericsson | 3.30% | $94.15K | $32.42B | 15.94% | 74 Outperform | |
| British American Tobacco | 3.28% | $93.41K | $126.65B | 54.07% | 59 Neutral |
GENW Technical Analysis
Positive
―
Price Trends
12.57
Positive
12.37
Positive
11.71
Positive
Market Momentum
0.09
Negative
64.14
Neutral
96.38
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GENW, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 12.67, equal to the 50-day MA of 12.57, and equal to the 200-day MA of 11.71, indicating a bullish trend. The MACD of 0.09 indicates Negative momentum. The RSI at 64.14 is Neutral, neither overbought nor oversold. The STOCH value of 96.38 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GENW.
GENW Peer Comparison
Comparison Results
Performance Comparison
GENW
Genter Capital International Dividend ETF
12.97
3.23
33.16%
FDIV
MarketDesk Focused U.S. Dividend ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
VWID
Virtus WMC International Dividend ETF
―
―
―
DIVD
Altrius Global Dividend ETF Altrius Global Divid ETF
―
―
―
GEND
Genter Capital Dividend Income ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents